HIGHLIGHTS
- who: . and collaborators from the Ludwig Maximilian University of Munich, Germany have published the paper: An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy, in the Journal: (JOURNAL)
- what: The authors used the data available in the public database to conduct a comprehensive pan cancer analysis of PSAT1 to determine the correlation between its expression and the prognosis of various malignant tumors. As seen in Figure 7A, PSAT1 expression is significantly correlated frontiersin.org 10.3389/fgene.2022.975381 Based on the results in Figure 7A, the authors show in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.